About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Conventional TACE
By
Symposium on Clinical Interventional Oncology (CIO 2018)
FEATURING
Timothy Clark
October 22, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
32:57
Merck Oncology
Case Studies Discussion on R/R cHL: Treatment Selection for Certain …
Feat.
W. Donnellan,
L. Leslie
Featured Video
18:52
Merck Oncology
A Treatment Option for Certain Patients With Locally Advanced or Met…
Feat.
C. Hoimes
Related Content
AUTOPLAY
ON
Boston Scientific
LEGACY: A Multicenter Study Confirming TheraSphere as a Neoadjuvant…
Mon, Oct 19, 2020
Faculty:
Boston Scientific
,
Vivian Bishay
Boston Scientific
Why Absorbed Dose Matters to Optimize Outcomes with SIRT: A Multi-Di…
Wed, Oct 20, 2021
Faculty:
Nora Tabori
,
Boston Scientific
,
Marwan Kazimi
,
Aparna Kaylan
,
Pavan Khanna
Boston Scientific
The Evolution of Dosimetry Using Y-90 Glass Microspheres
Wed, Nov 3, 2021
Faculty:
Juan Gimenez
,
Boston Scientific
,
Robert Lewandowski
,
Riad Salem
,
Shamar Young
08:21
Ripal Gandhi
Understanding Anatomy and Variants for Y-90 Radioembolization
19:58
Guerbet
GEST 2022 - Case Experiences with a Reflux Reduction Microcatheter i…
Feat.
S. Flanagan
02:18
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: How it’s Made
55:42
Boston Scientific
Select Locoregional therapies as a COVID-19 Risk Mitigation treatmen…
Feat.
E. Kim,
R. Salem,
P. Khanna,
J. Gimenez
60:29
Boston Scientific
Managing Interventional Oncology in the Time of Covid-19
Feat.
E. Kim,
R. Salem,
P. Khanna,
J. Gimenez
01:55
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: The LEGACY Study
26:23
Boston Scientific
The Changing Paradigm of Dosing and Dosimetry with Y90 Glass Microsp…
Feat.
S. Young
03:37
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres Animation
53:41
Terumo Interventional Systems
Radial Access for Liver and Pelvic Interventions – Live Case of HCC …
Feat.
M. Guimaraes,
S. Chen
02:20
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: The DOSISPHERE-01 Trial
02:25
Boston Scientific
TruSelect™ Microcatheter Animation
30:46
Boston Scientific
Dosimetry Series: Radiation Segmentectomy
Feat.
R. Hickey
19:19
David Liu
Radioembolization for MCRC: Latest Literature and Outcomes
32:43
Boston Scientific
Evolution of the HCC treatment: Optimized vs Standard Dosimetry
Feat.
E. Garin
24:12
SIR 2022 Coverage
New and Evolving Clinical Trials: Emolotherapy
Feat.
M. Soulen
30:30
Boston Scientific
Dosimetry Series: Radiation Lobectomy
Feat.
R. Lewandowski
10:06
Osman Ahmed
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresect…
24:55
Boston Scientific
Dosimetry Series: Introduction to Dosimetry
38:21
Beau Bosko Toskich
Ablative Radioembolization for the Treatment of Hepatocellular Carci…
11:18
Siddharth Padia
Y90 Radiation Segmentectomy
